Axplora is a premier API manufacturing partner to the world’s leading patient-centric pharmaceutical and biotechnology companies, delivering top quality active ingredients on time and at scale, to the highest industry standards. Axplora is dedicated to helping pharmaceutical companies make critical medicines better, faster, safely, reliably, and sustainably benefitting patients worldwide. Leveraging its combined expertise and manufacturing capabilities across nine industrial sites in Europe and India, and an R&D facility in the USA, Axplora offers CDMO solutions to innovators for their small molecule and biomolecular active pharmaceutical ingredients, as well as products that address lifestyle-induced respiratory, inflammatory and liver diseases. Headquartered in Raubling (near Munich, Germany), Axplora employs 2,400 people around the world.
Marks a key milestone in further enhancing Axplora’s ADC technology platform offering.
Raubling, 20 October 2022 – Farmabios, Novasep and PharmaZell officially announced today that they are coming together under the new brand Axplora. This announcement comes just 6 months after the closure of the merger of the Novasep and the PharmaZell Group. This marks the last step in the creation of Axplora, a leading Active Pharmaceutical Ingredients (API) manufacturing partner for pharmaceutical and biotechnology companies worldwide, with a long track record of reliably developing and scaling up complex production processes and delivering medicines on time and at scale, to the highest industry standards.